Skip to main content

Table 1 Baseline characteristics of patients with CA-UTI and other-cUTI (n = 807 episodes)

From: Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study

Factors

CA-UTI

(n = 341)

Other cUTI

(n = 466)

p-value

Male gender, n (%)

197 (57.8%)

222 (47.6)

0.006

Age, median (IQR)

71 (60–82)

68 (56.2–79)

0.009

Diabetes mellitus, n (%)

109 (32.2)

113 (24.2)

0.019

Haematological malignancy, n (%)

8 (2.3)

10 (2.1)

0.84

Solid tumour, n (%)

42 (12.3)

63 (13.8)

0.74

Liver disease, n (%)

16 (4.7)

26 (5.58)

0.68

Urgent admission, n (%)

285 (83.6)

394 (84.5)

0.78

Admission reason:

  

< 0.001

 Other reasons

213 (62.5)

120 (25.8)

 

 cUTI

128 (37.5)

346 (74.2)

 

Admission from medical care facility, n (%)

88 (25.8)

90 (13.5)

< 0.001

Charlson score, median (IQR)

3 (1–5)

2 (0–4)

< 0.001

Organ transplantation, n (%)

10 (2.9)

50 (10.7)

< 0.001

Immunosuppressive therapy, n (%)

19 (5.6)

63 (13.5)

< 0.001

Steroid therapy, n (%)

22 (6.5)

32 (6.87)

0.92

Functional capacity: Bedridden, n (%)

91 (26.7)

55 (11.8)

< 0.001

Chronic renal impairment, n (%)

72 (21.2)

141 (30.8)

0.005

UTI within 1 year, n (%)

79 (23.2)

143 (30.8)

0.021

Antibiotic within 30 days, n (%)

67 (19.7)

104 (22.5)

0.39

Acquisition of cUTI at a medical care facility, n (%)

254 (74.5)

160 (34.3)

< 0.001

Urinary retention, n (%)

70 (20.5)

112 (24)

0.27

Neurogenic bladder

32 (9.4)

12 (2.58)

< 0.001

Obstructive uropathy

43 (12.6)

166 (35.8)

< 0.001

Severity of infection: Severe sepsis/septic shock, n (%)

49 (15.4)

70 (15.9)

0.92

  1. CA-UTI catheter-associated urinary tract infection (CA-UTI), complicated urinary tract infection due to other sources (other-cUTI). IQR Interquartile range, cUTI complicated urinary tract infection, and UTI urinary tract infection